JPS52148060A - 17 betaaester of testosterone and alphaa dihydrotestosterone - Google Patents
17 betaaester of testosterone and alphaa dihydrotestosteroneInfo
- Publication number
- JPS52148060A JPS52148060A JP6170477A JP6170477A JPS52148060A JP S52148060 A JPS52148060 A JP S52148060A JP 6170477 A JP6170477 A JP 6170477A JP 6170477 A JP6170477 A JP 6170477A JP S52148060 A JPS52148060 A JP S52148060A
- Authority
- JP
- Japan
- Prior art keywords
- betaaester
- alphaa
- dihydrotestosterone
- testosterone
- alphaa dihydrotestosterone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 title 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 title 1
- 229960003473 androstanolone Drugs 0.000 title 1
- 229960003604 testosterone Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0025—Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/691,103 US4098802A (en) | 1975-02-18 | 1976-05-28 | Oral pharmaceutical preparation having androgenic activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS52148060A true JPS52148060A (en) | 1977-12-08 |
| JPS6145637B2 JPS6145637B2 (enrdf_load_stackoverflow) | 1986-10-08 |
Family
ID=24775172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6170477A Granted JPS52148060A (en) | 1976-05-28 | 1977-05-25 | 17 betaaester of testosterone and alphaa dihydrotestosterone |
Country Status (12)
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011519846A (ja) * | 2008-04-28 | 2011-07-14 | ダイアーナル リミテッド | 脂質組成物 |
| JP2016514706A (ja) * | 2013-03-15 | 2016-05-23 | リポカイン インコーポレーテッド | 経口送達用リポバランス長鎖テストステロンエステル |
| US9943527B2 (en) | 2010-11-30 | 2018-04-17 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US10561615B2 (en) | 2010-12-10 | 2020-02-18 | Lipocine Inc. | Testosterone undecanoate compositions |
| US11433083B2 (en) | 2010-11-30 | 2022-09-06 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US11559530B2 (en) | 2016-11-28 | 2023-01-24 | Lipocine Inc. | Oral testosterone undecanoate therapy |
| US12150945B2 (en) | 2018-07-20 | 2024-11-26 | Lipocine Inc. | Liver disease |
| US12310978B2 (en) | 2015-06-15 | 2025-05-27 | Lipocine Inc. | Composition and method for oral delivery of androgen prodrugs |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001291775B2 (en) * | 2000-08-23 | 2005-09-08 | N.V. Organon | Testosterone ester formulation for human use |
| JO2505B1 (en) | 2003-03-14 | 2009-10-05 | باير شيرنغ فارما اكتنجيسيلشافت | Pharmacy methods and formulations for obtaining acceptable serum testosterone levels |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL189235C (nl) * | 1974-02-28 | 1993-02-16 | Akzo Nv | Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking. |
-
1977
- 1977-05-20 GB GB21314/77A patent/GB1567515A/en not_active Expired
- 1977-05-24 CH CH640477A patent/CH627761A5/de not_active IP Right Cessation
- 1977-05-25 JP JP6170477A patent/JPS52148060A/ja active Granted
- 1977-05-26 FI FI771684A patent/FI57597C/fi not_active IP Right Cessation
- 1977-05-26 DE DE2723876A patent/DE2723876C2/de not_active Expired
- 1977-05-26 FR FR7716182A patent/FR2352832A1/fr active Granted
- 1977-05-26 NL NL7705790A patent/NL7705790A/xx not_active Application Discontinuation
- 1977-05-27 DK DK236877A patent/DK146096C/da not_active IP Right Cessation
- 1977-05-27 AR AR267807A patent/AR214323A1/es active
- 1977-05-27 ES ES459230A patent/ES459230A1/es not_active Expired
- 1977-05-27 BE BE178016A patent/BE855163A/xx not_active IP Right Cessation
- 1977-05-27 SE SE7706235A patent/SE425493B/xx not_active IP Right Cessation
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011519846A (ja) * | 2008-04-28 | 2011-07-14 | ダイアーナル リミテッド | 脂質組成物 |
| US9012436B2 (en) | 2008-04-28 | 2015-04-21 | Diurnal Limited | Lipid composition |
| US10881671B2 (en) | 2010-11-30 | 2021-01-05 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US11364249B2 (en) | 2010-11-30 | 2022-06-21 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9949985B2 (en) | 2010-11-30 | 2018-04-24 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US10226473B2 (en) | 2010-11-30 | 2019-03-12 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US11433083B2 (en) | 2010-11-30 | 2022-09-06 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US10799513B2 (en) | 2010-11-30 | 2020-10-13 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9943527B2 (en) | 2010-11-30 | 2018-04-17 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US10973833B2 (en) | 2010-11-30 | 2021-04-13 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US11311555B2 (en) | 2010-11-30 | 2022-04-26 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US11364250B2 (en) | 2010-11-30 | 2022-06-21 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US10561615B2 (en) | 2010-12-10 | 2020-02-18 | Lipocine Inc. | Testosterone undecanoate compositions |
| JP2016514706A (ja) * | 2013-03-15 | 2016-05-23 | リポカイン インコーポレーテッド | 経口送達用リポバランス長鎖テストステロンエステル |
| US12310978B2 (en) | 2015-06-15 | 2025-05-27 | Lipocine Inc. | Composition and method for oral delivery of androgen prodrugs |
| US11559530B2 (en) | 2016-11-28 | 2023-01-24 | Lipocine Inc. | Oral testosterone undecanoate therapy |
| US12150945B2 (en) | 2018-07-20 | 2024-11-26 | Lipocine Inc. | Liver disease |
Also Published As
| Publication number | Publication date |
|---|---|
| GB1567515A (en) | 1980-05-14 |
| FR2352832B1 (enrdf_load_stackoverflow) | 1980-07-11 |
| DE2723876A1 (de) | 1977-12-15 |
| ES459230A1 (es) | 1978-11-16 |
| BE855163A (fr) | 1977-11-28 |
| DK236877A (da) | 1977-11-29 |
| CH627761A5 (en) | 1982-01-29 |
| FI771684A7 (enrdf_load_stackoverflow) | 1977-11-29 |
| DK146096B (da) | 1983-06-27 |
| SE425493B (sv) | 1982-10-04 |
| NL7705790A (nl) | 1977-11-30 |
| DK146096C (da) | 1983-11-21 |
| FI57597C (fi) | 1980-09-10 |
| SE7706235L (sv) | 1977-11-29 |
| FI57597B (fi) | 1980-05-30 |
| DE2723876C2 (de) | 1986-10-30 |
| FR2352832A1 (fr) | 1977-12-23 |
| AR214323A1 (es) | 1979-05-31 |
| JPS6145637B2 (enrdf_load_stackoverflow) | 1986-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5395989A (en) | Substituted 11thienyl and furyll 2*3*4*55tetrahydroo1hh33benzazepine compound | |
| JPS52100446A (en) | Compositions and process | |
| JPS5293535A (en) | Haymaker having functions of mowering and drying | |
| JPS53141292A (en) | Novel imidazoazine and * imidazodiazine | |
| ZA772084B (en) | Testosterone 5a-reductase inhibitors | |
| JPS51131880A (en) | 11*3*3*33triarylpropyl**44 phenyll44piperidinemethanol and analogous compounds | |
| JPS52148060A (en) | 17 betaaester of testosterone and alphaa dihydrotestosterone | |
| GB1539021A (en) | Arrangements and devices for facilitating the movement of luggage | |
| JPS5289650A (en) | Compositions and process | |
| JPS52139040A (en) | 22 and 33substituted enekephlin | |
| JPS5289648A (en) | Compositions and process | |
| JPS54106462A (en) | 33*nnacyllnnarylamino**gammaabutyrolactone and gammaabutyrothiolactone | |
| JPS53132582A (en) | 33*11piperadinyl**1*2*44benzotriazine and nnoxide | |
| JPS52153975A (en) | Dihydroo and tetrahydroo iminothazidine | |
| JPS52133954A (en) | Compositions and process | |
| JPS52133995A (en) | 1*2*44thiadiazinone and its preparation and application thereof | |
| JPS527966A (en) | 99hydroxyy7*8*9*100tetrahydroo 6hhdibenzo*b**d*bilanes and bilanones | |
| PH13879A (en) | D-homo steroid and composition containing the same | |
| JPS5295660A (en) | Tetrapeptideamide and intermediate thereof | |
| JPS5365853A (en) | 15 * 166dihydroxyprostaglandin and like | |
| JPS52100449A (en) | Compositions and process | |
| NZ185779A (en) | Derivatives of ortho-aminoacetophenone and pharaceutical compositions | |
| JPS52108979A (en) | 33substitutedd55phenyll55pyridylhydantoin and antiiarrhythmic agents | |
| PH14030A (en) | Derivatives of 2-iminothiazolidine and 2-iminothiazoline | |
| GB1548830A (en) | Metaphenylenediamines and dyeing compositions containing them |